A DUNFERMLINE man's family are fearful "critical" medicine may no longer be accessible after Brexit.

Jonathan Fisher has a rare genetic disorder called Lowe Syndrome which mainly affects his brain, eyes and kidneys.

The 25-year-old, known as 'the Bold Joff', has profound and multiple physical, sensory and learning difficulties and complex healthcare needs.

He requires adult support round the clock in all areas of his life and takes six regular medications to keep him well.

Four of them are taken multiple times a day and three of these are made in the EU – France, Spain and Italy – and one of which is critical to treat his epilepsy.

His family are concerned about the future of the supply of this medication and have already made arrangements with their GP and pharmacy to have a small, extra supply of these EU-based medicines.

MP for Dunfermline and West Fife Douglas Chapman met Jonathan recently and has raised the family's fears to health secretary Matt Hancock.

He said: "Cases like this really bring home the real-life impact of Brexit.

"This medication is vital for people like Jonathan and others across the UK and it shows the lack of preparation and communication by the Tory Government that families are still being left in the dark as to whether they will have access to vital medicines.

"This is causing extreme worry and anxiety for Jonathan’s family. They dedicate so much of their time to look after him and need to know if they will be able to continue to care for him successfully.

"I would urge the government to seek a guarantee that supplies of vital medicines will continue after Brexit, deal or no deal.”

Fiona Fisher, Jonathan’s mum, added: "We are very grateful to Douglas for raising this issue on our behalf as I'm sure it will also be of concern to many of his constituents in Dunfermline and West Fife who rely on EU medications and medical supplies.

“I hope the UK Government make continued supplies of such medications a priority in the event of a no-deal Brexit."